Tag: quikchange ii site directed mutagenesis kit

Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis

Multifocal tuberculosis simulating multimetastatic colon cancer in an immunocompetent black African patient: a case report

Pulmonary tuberculosis is a extremely prevalent respiratory illness that impacts roughly 1 / 4 of the world’s inhabitants. The drug remedy protocol for tuberculosis is advanced as a result of the Mycobacterium tuberculosis (M. tuberculosis) invades macrophages and begins to Read more…